The downside of downregulation
This scientific commentary refers to ‘Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms’, by Avram et al.(doi:10.1093/brain/awz093).
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Article (Journal) Editorial |
| Lingua: | inglese |
| Pubblicazione: |
28 May 2019
|
| In: |
Brain
Year: 2019, Volume: 142, Fascicolo: 6, Pages: 1500-1502 |
| ISSN: | 1460-2156 |
| DOI: | 10.1093/brain/awz133 |
| Accesso online: | Verlag, Volltext: https://doi.org/10.1093/brain/awz133 Verlag: https://academic.oup.com/brain/article/142/6/1500/5499011 
|
| Note sull'autore: | Gerhard Gründer and Paul Cumming |
| Riassunto: | This scientific commentary refers to ‘Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms’, by Avram et al.(doi:10.1093/brain/awz093). |
|---|---|
| Descrizione del documento: | Gesehen am 11.11.2019 |
| Descrizione fisica: | Online Resource |
| ISSN: | 1460-2156 |
| DOI: | 10.1093/brain/awz133 |